Rockwell Medical Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
51.77 M |
Public Float |
41.92 M |
Rockwell Medical Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.66 |
Market Cap |
$189.56 M |
Shares Outstanding |
63.4 M |
Public Float |
45.56 M |
Address |
30142 Wixom Road Wixom Michigan 48393 United States |
Employees | - |
Website | http://www.rockwellmed.com |
Updated | 07/08/2019 |
Rockwell Medical, Inc. is a biopharmaceutical company, which operates through Hemodialysis Market segment that engages in the manufacture, sale, and distribution of hemodialysis products to hemodialysis clinics including pharmaceutical, dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. Its dialysis products include Triferic, Calcitriol Vitamin D Injection, Hemodialysis Concentrates, CitraPure, Dri-Sate, and ancillary products. The company was founded by Robert L. |